NCT06034106

Brief Summary

Osteoarthritis is the most common type of arthritis among rheumatologic diseases. Complementary therapies are one of the effective methods for pain control. This study was planned as a randomized controlled experimental study. For this purpose, patients diagnosed with knee osteoarthritis who applied to the Orthopedics Outpatient Clinic will be included. It was calculated that the study would include at least 67 patients. The study will be collected using patient information form, descriptive characteristics form, Visual Analog Scale (VAS) and WOMAC osteoarthritis application scale. It was planned as a randomized controlled experimental study to evaluate the effect of pomegranate peel (P. granatum) compress application on pain and function status. The study was divided into 3 groups as Pomegranate (Punica granatum) peel compress, hot compress and control group. Pomegranate (Punica granatum) peel compress was applied 3 days a week for 3 weeks by turning the powder into porridge check.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
67

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 14, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 8, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 13, 2023

Completed
17 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2023

Completed
Last Updated

September 13, 2023

Status Verified

September 1, 2023

Enrollment Period

6 months

First QC Date

August 8, 2023

Last Update Submit

September 5, 2023

Conditions

Keywords

painosteoarthritisrheumatologic diseasesphysical functionstiffnessnursing

Outcome Measures

Primary Outcomes (2)

  • Visual Analog Scale

    A VAS consisting of a 10-centimeter horizontal line, anchored evenly by numbers from 0 to 10, was used to assess the patient's pain and willingness to repeat the procedure. The number 0 was identical to having no pain while the number 10 corresponded to maximal pain that can be experienced by the patient

    The scale was filled in the baseline

  • WOMAC Osteoarthritis Index

    The WOMAC index is composed of 24 items and 3 subdimensions (pain, stiffness, and physical function). The participants are asked to rate pain (5 questions), stiffness (2 questions), and difficulties encountered in physical functioning (17 questions) during the day (24 hours). The index is a 5-point Likert-type scale, where 0 is none, 1 mild, 2 moderate, 3 severe, and 4 very severe. Pain scores range from 0e20 points, stiffness scores from 0e8 points, and difficulties in physical function scores from 0e68 points. Higher scores indicate increased pain and stiffness, impairment in physical functioning, and higher levels of physical limitation.

    The scale was filled in the baseline

Study Arms (3)

Pomegranate (P. granatum) peel compress group

EXPERIMENTAL

36 g of pomegranate peel powder was given to the patient in a closed container. A teaspoon (approximately 2-3 g) of powder was mixed with water from the storage container and applied to the patient's knee by making a paste, and then the knee was wrapped with a bandage. It was kept for 20 minutes by placing a hot thermophore (approximately 40-45 C) on it. This application was carried out 3 days a week.

Behavioral: Pomegranate (Punica granatum) peel compress

Hot compress

PLACEBO COMPARATOR

In the hot compress group, the knee was wrapped with a bandage and the hot thermophor (approximately 40-45 °C) was placed on the knee. The hot thermoform was applied to the patient 3 days a week by keeping it for 20 minutes.

Behavioral: Pomegranate (Punica granatum) peel compressBehavioral: Hot compress

Control Group

NO INTERVENTION

Patients in the control group did not receive any additional intervention.

Interventions

Pomegranate (Punica granatum) peel compress was applied 3 days a week for 3 weeks by turning the powder into porridge check.

Hot compressPomegranate (P. granatum) peel compress group
Hot compressBEHAVIORAL

Hot compress was applied 3 days a week for 3 weeks.

Hot compress

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Visual analog scale score of 3 and above,
  • those aged 45 and over,
  • Diagnosed with knee OA by a physician according to the criteria of the American - Rheumatology Association (ARD),
  • pain lasting at least 1 month or longer,
  • not included in any physical therapy program during the research period, a
  • capable of answering research questions,
  • agreeing to participate in the research by giving verbal and written consent

You may not qualify if:

  • with a defined psychiatric illness,
  • having vision and hearing problems,
  • diagnosed with complex disease such as malignant,
  • having a wound in the application area,
  • with a diagnosed vascular disease,
  • the patient's other inflammatory disease such as rheumatoid arthritis, gout, fibromyalgia
  • who have had serious trauma or surgery in the last 6 months,
  • who have received DMARDS or intra-articular steroid injection therapy in the last 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dilek Efe Arslan

Kayseri, Melikgazi, 38280, Turkey (Türkiye)

Location

MeSH Terms

Conditions

PainOsteoarthritis

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • DİLEK EFE ARSLAN

    ERCİYES UNİVERSİTY

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
ErciyesU

Study Record Dates

First Submitted

August 8, 2023

First Posted

September 13, 2023

Study Start

April 14, 2023

Primary Completion

September 30, 2023

Study Completion

October 15, 2023

Last Updated

September 13, 2023

Record last verified: 2023-09

Locations